Reviewed by Michael Gill, B. Sc.
6 Peripheral T Cell Lymphoma Clinical Trials Near Me
Top Hospitals for Peripheral T Cell Lymphoma Clinical Trials
Image of University of Maryland in Maryland.
University of Maryland
Baltimore
2Active Trials
5All Time Trials for Peripheral T Cell Lymphoma
2010First Peripheral T Cell Lymphoma Trial
Image of Clinical Site in Tennessee.
Clinical Site
Nashville
1Active Trials
1All Time Trials for Peripheral T Cell Lymphoma
2021First Peripheral T Cell Lymphoma Trial
Top Cities for Peripheral T Cell Lymphoma Clinical Trials
Image of Duarte in California.
Duarte
4Active Trials
City of Hope Comprehensive Cancer CenterTop Active Site
Image of Nashville in Tennessee.
Nashville
2Active Trials
Clinical SiteTop Active Site
Peripheral T Cell Lymphoma Clinical Trials by Phase of Trial
Phase 1 & 2 Peripheral T Cell Lymphoma Clinical Trials
3Active Peripheral T Cell Lymphoma Clinical Trials
3Number of Unique Treatments
11Number of Active Locations
Peripheral T Cell Lymphoma Clinical Trials by Age Group
18+ Peripheral T Cell Lymphoma Clinical Trials
6Active Peripheral T Cell Lymphoma Clinical Trials
Most Recent Peripheral T Cell Lymphoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Top Treatments for Peripheral T Cell Lymphoma Clinical Trials
Treatment Name
Active Peripheral T Cell Lymphoma Clinical Trials
All Time Trials for Peripheral T Cell Lymphoma
First Recorded Peripheral T Cell Lymphoma Trial
MT-101
1
1
2021
brentuximab vedotin
1
5
2012
cabiralizumab
1
1
2019
Nivolumab and EPOCH
1
1
2018
Duvelisib
1
5
2018
Recently Completed Studies with FDA Approved Treatments for Peripheral T Cell Lymphoma
Treatment
Year
Sponsor
rhIL-15
2019
National Cancer Institute (NCI)
Anti-CD30-CAR T cells
2017
National Cancer Institute (NCI)

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 13th, 2021

Last Reviewed: November 16th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Valipour A, Jäger M, Wu P, Schmitt J, Bunch C, Weberschock T. Interventions for mycosis fungoides. Cochrane Database Syst Rev. 2020 Jul 7;7:CD008946. doi: 10.1002/14651858.CD008946.pub3. https://pubmed.ncbi.nlm.nih.gov/32632956